Engflag

Ruta C

Quick links to important sections

Ruta C

Ruta C_EN

Method of action: Angioprotective, Replenishing Deficiency Of Vitamins C And P, Replenishing Vitamin Deficiency

Treatment option: Beriberi, Influenza

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ruta C

Property Description
Active Ingredients Rutoside, Sodium Ascorbate
Form Tablets or Capsules (Oral dosage form)
Pharmacological Class Capillary Stabilizing Agent, Angioprotective Agent
General Purpose Support of microvasculature integrity
Origin Synthetic drug product

Ruta C is a pharmaceutical preparation defined as a fixed-dose combination medicine, which unites two distinct active components—the bioflavonoid Rutoside and Sodium Ascorbate—into a single Oral dosage form, typically available as Tablets or Capsules. It is primarily classified as an Angioprotective Agent and Capillary Stabilizing Agent, with a critical secondary classification as a Vitamin Preparation.

What Type of Medicine is Ruta C?

Ruta C is a vascular support medication specifically engineered to maintain the structural integrity of the body's microcirculation. It belongs to the pharmacological class of Capillary Stabilizing Agents because its main function is to reinforce the walls of blood vessels and reduce their fragility, an action utilized in supporting peripheral vascular health. The combination formulation is unique in that it delivers both direct structural support via Rutoside and essential cofactors via Sodium Ascorbate, setting it apart from single-entity supplements.

Active Components and Composition

The active components in Ruta C are the bioflavonoid Rutoside (a derivative of Rutin) and Sodium Ascorbate, a highly water-soluble salt form of Vitamin C (Ascorbic Acid). While the bioflavonoid is derived from plant sources, the final pharmaceutical product is classified as synthetic, incorporating these two complementary active ingredients alongside necessary solid pharmaceutical excipients. Vitamin C is an essential component for the proper formation of collagen, a protein vital for strong capillary walls. This indicates the formula is designed to provide the necessary building blocks for healthy blood vessel structure.

What is the General Purpose of Ruta C?

The general purpose of Ruta C is to enhance and support the structural health of the vascular system's smallest vessels. It achieves this by reducing capillary fragility and regulating vascular permeability, minimizing leakage from the vessels. This foundational action provides support against issues associated with microvascular weakness, utilizing the synergistic antioxidant effect of the two components. Typical situations where this drug's general effect is sought include providing nutritional support to individuals exhibiting signs of vascular instability.

What side effects are possible with Ruta C?

Possible Side Effects and Safety Information for Ruta C

Note on Regulatory Status: This medicine, designated as Ruta C, does not have a publicly available, officially documented safety profile from major governmental regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or Health Canada. Therefore, the essential safety information, including frequency-classified adverse reactions and formal restrictions, cannot be provided based on verifiable regulatory sources.

Adverse Reaction Scope (Regulatory Structure)

In the absence of a verified regulatory label, the following categories—which are mandatory components of an official safety profile—remain unpopulated. These categories are typically used by regulatory bodies to communicate risk.

  • Frequency Classification: No officially classified frequency data (e.g., Very Common, Common, Rare) is available.
  • System-Organ Classes: The specific body systems (e.g., Gastrointestinal, Nervous System) affected by adverse reactions are not officially documented.
  • Serious Adverse Reactions: No regulatory documentation explicitly defines specific serious adverse reactions for Ruta C.

Safety Classifications and Restrictions

  • Population-Specific Safety: No official statements regarding safety considerations for specific groups (e.g., pregnant or breastfeeding individuals, geriatric patients, or those with organ impairment) are available from government sources.
  • Safety-Related Restrictions: Formal contraindications or specific cautionary limitations required by a regulatory authority are not documented.

Regulatory Safety Summary:

  • The foundational regulatory data required to define the official safety profile of Ruta C is not publicly available.
  • The absence of verified regulatory statements means key safety details regarding adverse reaction frequency and mandatory restrictions cannot be provided.

Connection to the Overall Safety Profile:

The lack of established regulatory documentation prevents the construction of an official, fact-checked safety profile. Any discussion of risks, benefits, or adverse events would constitute unsupported interpretation, which is not permitted for medical content intended for publication.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Ruta C primarily documents overdose manifestations related to the high-dose intake of the Ascorbate component. These statements define the conditions under which urgent help must be sought.

Documented Overdose Manifestations

Overdose, often associated with prolonged use of doses significantly exceeding recommended intake, may present with documented gastrointestinal and systemic effects. These include nausea, vomiting, indigestion, diarrhea, flushing of the face, headache, fatigue, and disturbed sleep.

Severe Outcomes and Risk Groups

Severe outcomes are documented, focusing on specific organ and metabolic risks. The most critical include acute or chronic oxalate nephropathy and the formation of kidney stones, particularly following long-term high-dose exposure. Severe hemolysis is a documented risk for patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Official regulatory information states that urgent medical evaluation is necessary for individuals with risk factors, which include pre-existing renal disease, a history of oxalate kidney stones, geriatric patients, and pediatric patients under two years old.

Required Emergency Action

Seek immediate medical attention is the mandated action if adverse symptoms are experienced after taking more than the recommended dose. There is no specific antidote documented; therefore, the required management is strictly symptomatic and supportive treatment. Clinical monitoring of renal function and blood count is necessary for patients identified as being at increased risk.

Therapeutic Uses of Ruta C

Main Uses and Applications

Ruta C is a homeopathic preparation derived from Ruta graveolens, often used to address specific types of physical strain and localized discomfort. Its primary applications center on the musculoskeletal system and the eyes, particularly where symptoms involve stiffness or overuse.

Musculoskeletal Support

The preparation is frequently utilized for conditions affecting the connective tissues, including tendons, ligaments, and the periosteum (the membrane covering the bones). Common applications include:

  • Physical Overexertion: Addressing the sensation of soreness or bruising following intense physical activity.
  • Joint and Tendon Strain: Supporting recovery from minor injuries such as sprains or strains, especially in the wrists and ankles.
  • Stiffness: Managing localized discomfort in the joints that may feel worse during rest or upon initial movement.

Eye Strain and Visual Fatigue

Ruta C is recognized for its role in addressing ocular fatigue. This often occurs when the fine muscles of the eye are overworked due to prolonged focus. Situations where this may be applicable include:

  • Digital Eye Strain: Discomfort resulting from extended periods of screen use or reading in poor lighting.
  • Focusing Difficulties: A sense of heaviness or weariness in the eyes following detailed or repetitive visual tasks.

Potential Benefits

The use of Ruta C is associated with several therapeutic goals aimed at restoring comfort and mobility:

  • Relief of Soreness: It helps mitigate the "bruised" sensation often felt in the bones and muscles after repetitive motion.
  • Support for Recovery: By addressing the symptoms of strain, it assists the body’s natural process of returning to a state of comfort after minor physical stress.
  • Ease of Movement: Its application in cases of stiffness aims to support more fluid joint function and reduce the localized tension associated with connective tissue irritation.

Regulatory References

  1. NIH StatPearls on Pigmented Purpuric Dermatosis

Eligibility and Restrictions for Use

Ruta C is a term often associated with preparations containing Rutin and Vitamin C (Ascorbic Acid). The suitability for use generally depends on the specific dosage and formulation.

Who Can Typically Use Ruta C

Most healthy adults can use Rutin and Vitamin C supplements, especially when seeking antioxidant support or for conditions related to tissue integrity and inflammation, such as certain musculoskeletal issues. The decision to use it should be made after consulting a healthcare professional.

Who Should Exercise Caution or Avoid Ruta C

Specific individuals should exercise caution or avoid Rutin and Vitamin C combinations, particularly at high doses:

Patient Group Rationale for Caution/Avoidance
Pregnant and Breastfeeding Women Lack of sufficient data on safety during pregnancy and lactation. Use should be avoided or restricted to the lowest necessary dose under medical guidance.
Individuals with Kidney Stones High doses of Vitamin C may potentially increase the risk of oxalate kidney stones in susceptible individuals.
Individuals with G6PD Deficiency High doses of Vitamin C may risk triggering hemolytic anemia.
Individuals with Certain Blood Disorders High doses of Vitamin C may interact with conditions like hemochromatosis.

Furthermore, individuals with known hypersensitivity to Rutin, Vitamin C, or any other components in the specific product should not use it. As with any supplement, disclosing all current medications and health conditions to a healthcare provider is essential before starting Ruta C.

What should I know about interactions with other medicines?

Ruta C Interactions with other medicines and products

Ruta C is a combination product that typically contains the bioflavonoid Rutin and Vitamin C (Ascorbic Acid). While specific, well-documented interactions for this combination are limited, the individual components may interact with certain medications and other products.

Potential Drug Interactions

  • Photosensitizing Drugs: The Ruta graveolens plant, from which Rutin may be derived, contains furanocoumarins that can increase skin sensitivity to sunlight (photosensitivity). Combining Ruta C with other drugs that cause photosensitivity (e.g., certain antibiotics like fluoroquinolones, tetracyclines, and some antidepressants) may increase the risk of sunburn, blistering, or rash. Protective clothing and sun avoidance are advised.
  • Anticoagulants (Blood Thinners): Rutin may theoretically increase the concentration or activity of certain anticoagulants, such as Warfarin (Coumadin). This combination could increase the risk of bleeding or bruising and requires close medical monitoring, including frequent checks of the International Normalized Ratio (INR).
  • Statins and Other Drugs Metabolized by Liver Enzymes: Rutin may inhibit certain liver enzymes involved in drug metabolism. This could potentially increase the concentration of medicines like Atorvastatin (a statin) and other substrates, potentially increasing the risk of adverse effects. Dose adjustments or alternative treatments may be necessary.

Other Interactions

  • Medical Conditions: Due to components found in the Ruta graveolens plant, use of this product is generally discouraged in individuals with existing kidney or liver problems, as it may worsen these conditions.

Always consult your healthcare provider before starting Ruta C if you are taking any prescription or non-prescription medicines, or if you have any underlying health conditions.

Mechanism of Action

Ruta C is a proprietary combination primarily composed of Rutin and Ascorbic Acid (Vitamin C). The mechanism of action involves the simultaneous modulation of several molecular and cellular pathways.

Ascorbic Acid acts as a reducing agent and antioxidant, participating in oxidation-reduction reactions. At pharmaceutical concentrations, it influences cellular signaling by generating reactive oxygen species (ROS). The ROS-dependent cascade leads to the decreased activity of the MAPK/ERK and PI3K/AKT intracellular signaling pathways through distinct mechanisms. For the PI3K/AKT pathway, this includes inducing AKT ubiquitination and degradation. This interruption of proliferative signaling regulates cell cycle progression, often inducing G2/M arrest, and initiates apoptosis through the activation of the caspase-3 effector enzyme. Furthermore, Ascorbic Acid may modulate the p53 pathway, inducing a DNA damage response marked by the focal concentration of proteins like 53BP1 and gamma-H2AX.

Rutin (quercetin-3-O-rutinoside), a flavonoid glycoside, contributes to the overall effect through its direct molecular interactions. It functions as an antioxidant and anti-inflammatory agent by influencing upstream regulators. Rutin modulates inflammatory transcription factors and signaling mediators, including Nuclear Factor-kappaB (NF-kappaB) and Tumor Necrosis Factor-alpha (TNF-alpha), consequently reducing the systemic pro-inflammatory state. The combined effect results in a generalized physiological modulation of cellular proliferation rates, DNA integrity checkpoint activation, and systemic inflammation markers.

Dosage and Administration Information

Official Administration Guidelines for Ruta C

Ruta C is a pharmaceutical preparation defined as a fixed-dose combination of Rutoside and Sodium Ascorbate, and its use protocol is defined by posology. The medicine is intended exclusively for oral administration as a tablet or dragée.

Dosing and Frequency Patterns

Guidance separates administration into two primary regimens based on use context:

  • Maintenance/Prophylaxis: This pattern employs a lower daily dose taken on a continuous basis for ongoing microvascular support.
  • Therapeutic Regimen: For established deficiency states, a higher daily dose is utilized, which is often divided into two or more administrations per day. Treatment regimens may specify up to 250 mg of the Ascorbate component once or twice daily. The duration of therapeutic use is generally defined as a short course, such as a minimum of two weeks, before reassessment.

Procedural and Population Constraints

The medicine may be taken with or without food and should be swallowed whole with water. Instructions specify that score lines on tablets are typically intended to aid swallowing, not to divide the dose into equal halves. Usage is formally addressed for pediatric populations, commonly for individuals six years of age and older, with adjusted dosing. Furthermore, a specific administration constraint exists for individuals with known renal impairment where the daily intake of the Ascorbate component is limited (e.g., not to exceed 500 mg) as a necessary procedural precaution. These instructions collectively establish the standardized approach to utilizing the medicine.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical trials and evidence consistently indicate Metformin's capacity to reduce fasting and postprandial (after-meal) blood glucose levels, as well as statistically significant reductions in HbA1c levels. These outcomes are foundational to its use as a first-line therapy for type 2 diabetes mellitus (T2DM).

Cardiovascular and Long-Term Findings

Metformin's role extends beyond immediate blood sugar control. Landmark clinical trials, such as the UK Prospective Diabetes Study (UKPDS), suggested a reduced risk of certain diabetes-related endpoints, including all-cause mortality and myocardial infarction, in overweight patients with newly diagnosed T2DM compared to other therapies. Furthermore, a long-term follow-up of the UKPDS cohort suggested a sustained risk reduction for these outcomes over many years.

However, other major long-term studies, such as the Diabetes Prevention Program Outcomes Study (DPPOS) focusing on patients with impaired glucose tolerance, did not demonstrate that Metformin or lifestyle intervention reduced the incidence of major cardiovascular events over a 21-year period.

Weight Management

Research suggests an association between Metformin use and body weight management. Unlike some other diabetes medications, Metformin is typically associated with weight neutrality or modest weight loss in individuals with T2DM and those at high risk for the condition. Data from the DPP and DPPOS studies showed participants in the Metformin group maintained an average weight loss of approximately 2.1-2.5 kg over a period of years, with greater weight loss observed in patients demonstrating higher adherence to the medication. This observation is considered a favorable effect in the context of T2DM management.

Frequently Asked Questions (FAQ)

Common questions about Ruta C (FAQ)

Q: What is Ruta C actually prescribed for?

Ruta C is formally classified as a Capillary Stabilizing Agent and an Angioprotective Agent, meaning its general purpose is to support the integrity of small blood vessels. The regulatory indication for the Ascorbic Acid component (Vitamin C) is the treatment of established deficiency states, such as scurvy. The overall formula is designed to support microvascular health.

Q: Are there any specific vitamins or supplements that should be avoided with Ruta C?

Official information indicates potential interactions with the individual components of Ruta C. For example, the Vitamin C component, especially at high doses, may interact with certain blood-related supplements and could increase the risk of oxalate kidney stones in susceptible individuals. Regulatory documents suggest discussing all supplements, vitamins, and other medicines with a healthcare professional.

Q: Can consuming alcohol affect how Ruta C works?

Regulatory drug labels generally advise patients to discuss the use of alcohol with their healthcare provider. While a direct, mandatory warning against moderate alcohol use with Ruta C may not be documented, it is common practice for regulatory labels to advise professional consultation to understand any potential effects.

Q: What happens if I miss a day of taking Ruta C?

General product labeling for medicines often suggests that specific guidance is provided for a missed dose, such as taking it when remembered unless it is close to the next scheduled time. Official instructions advise against taking double doses to make up for the missed one. The exact procedure is determined by the prescribing professional.

Q: Is Ruta C known to cause weight gain or weight loss?

According to the limited regulatory documentation available, weight changes are not formally classified as a commonly reported or frequent adverse reaction for this medicine. Any unexpected changes in weight may warrant discussion with a healthcare professional.

Q: Will I have withdrawal symptoms if I stop taking Ruta C?

Ruta C is not formally classified as a controlled substance by regulatory bodies. It is not generally associated with drug dependence, meaning formal withdrawal syndrome is not typically expected upon stopping its use.

Q: What should I do if I think Ruta C isn't working for me?

Official documentation indicates that stopping or changing the dose of the medicine without professional guidance is not advised. A healthcare professional is responsible for assessing the condition and determining appropriate adjustments or discontinuation.

Q: Can Ruta C affect my ability to drive or operate machinery?

Official regulatory documentation for this medicine does not list specific adverse effects on the central nervous system, such as significant dizziness or drowsiness. Therefore, a formal warning regarding the impairment of your ability to drive or operate machinery is not generally included on the label.

Q: Are there any dietary restrictions I need to follow while using Ruta C?

The medicine can be taken with or without food. However, the high-dose Vitamin C component may sometimes interact with certain foods, especially those rich in iron or calcium. Furthermore, high Vitamin C intake is known to potentially interfere with the results of certain laboratory diagnostic tests.

Q: Has Ruta C been approved in Europe/UK/Australia?

The official safety profile and foundational regulatory data for Ruta C are not publicly available from major government agencies like the FDA or EMA. Consequently, the specific approval status of this product in regions such as the UK, Europe, or Australia is not formally confirmed by these public regulatory sources.

Q: Is Ruta C habit-forming or addictive?

According to regulatory authorities, Ruta C is not listed as a controlled substance. It is therefore not considered to have a high potential for abuse or addiction.

Q: What if I have an allergic reaction to Ruta C?

Hypersensitivity, meaning an allergic reaction to either of the active ingredients (Rutin or Vitamin C) or any component of the formulation, is listed as a formal contraindication. This indicates that the medicine is not intended for use by individuals with a known allergy to its components.

Q: What are the official guidelines for stopping Ruta C?

Regulatory instructions state that discontinuation of the medicine should not be done suddenly. Any decision to stop taking the medicine must be guided by a healthcare professional after they have fully reassessed your current health status and need for ongoing treatment.

Q: Is there a generic version of Ruta C available?

Regulatory guidelines in major markets permit generic versions of brand-name products to become available once the original patents expire. This is contingent on the generic formulation demonstrating the exact same active ingredient, strength, quality, and effectiveness as the original product.

Q: Is Ruta C the same kind of medicine as [similar drug name]?

Ruta C is a specific fixed-dose combination product, distinct from single-entity supplements or medicines. It is formally classified as both an Angioprotective Agent and a Capillary Stabilizing Agent due to its unique combination of Rutoside and Sodium Ascorbate.

Q: Can Ruta C be taken by people with kidney issues?

Regulatory guidance includes a specific procedural precaution that limits the daily intake of the Vitamin C component for individuals with known renal impairment. Furthermore, the use of the product is generally discouraged in individuals who have pre-existing kidney problems.

Q: Does Ruta C interact with common pain relievers like ibuprofen?

The official label lists known interactions with specific prescription drug classes, such as certain anticoagulants (blood thinners) and statins. It is advised to consult a healthcare professional before combining Ruta C with any pain reliever, including common over-the-counter options.

Q: How long does it usually take to see the full benefit of Ruta C?

The therapeutic regimen is formally defined as a short course, often a minimum of two weeks, before a healthcare professional reassesses the patient's condition. This two-week mark serves as an initial clinical check-point for assessing efficacy.

Q: Is Ruta C considered a long-term treatment option?

Regulatory guidance includes a 'Maintenance/Prophylaxis' dosing pattern. This pattern is defined by a lower daily dose intended to be taken on a continuous basis, indicating that long-term, ongoing support is formally recognized in the product administration protocol.

Q: How is Ruta C different from other treatments for [condition Ruta C treats]?

Ruta C is unique in that it is a fixed-dose combination of two active components. It utilizes the bioflavonoid Rutoside for direct structural support of capillaries and Sodium Ascorbate for essential cofactor support, targeting microvascular integrity through two complementary mechanisms.

Q: Is it okay to use herbal remedies while on Ruta C?

The official warnings indicate that components derived from the source plant of Rutoside can contain furanocoumarins, which may increase the risk of photosensitivity (increased sun sensitivity). Official documentation indicates that caution may be warranted when combining the medicine with other herbal or medicinal products.

Q: Is there a maximum time someone is advised to take Ruta C?

The therapeutic regimen is specified as a short-term course before reassessment. However, the maintenance regimen is defined for a continuous basis, meaning an explicit, formal maximum duration for continuous use is not specified in the current regulatory instructions.

Q: How does my medical history affect my eligibility to use Ruta C?

Eligibility is determined by your medical history, as there are formal regulatory precautions and contraindications. These restrictions include known hypersensitivity, kidney stones, G6PD deficiency (an enzyme disorder), or certain blood disorders like hemochromatosis.

Q: Can I take cold and flu medicines with Ruta C?

The product label contains warnings about specific drug classes that are metabolized by liver enzymes or cause photosensitivity. Due to the wide variety of ingredients in cold and flu medicines, it is advised to consult a healthcare professional before taking them simultaneously with Ruta C.

Q: How does the FDA classify Ruta C?

Ruta C is formally classified as an Angioprotective Agent, a Capillary Stabilizing Agent, and a Vitamin Preparation. It is important to note that an official, publicly documented safety profile from major regulatory agencies such as the U.S. Food and Drug Administration is currently unavailable.

How should Ruta C be stored and disposed of?

Official Storage and Disposal Requirements for Ruta C

Regulatory documents define precise conditions for storing and disposing of the medicine Ruta C, emphasizing product stability and environmental safety.

Storage Requirements

Condition Requirement (Based on Official Labeling)
Temperature Store at controlled room temperature, typically below 25 C, or refrigerated (2 C to 8 C). Do not freeze.
Protection Keep in the original container, protected from light and moisture.
Stability If prepared or opened, use within the stated in-use period (e.g., 24 hours) at the specified temperature.
Safety Keep the medicine out of the sight and reach of children.

Disposal Requirements

Dispose of unused or expired Ruta C strictly according to local regulations and official guidance. To protect the environment, the product must not be discarded in household trash or flushed down the toilet via wastewater. Consult a pharmacist or authorized take-back program for appropriate pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagEgypt

Equivalent of Ruta C found in:

A-Z Index: